C-MYC ONCOGENE

Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review
Bede van Schaijik, Paul F Davis, Agadha C Wickremesekera, Swee T Tan, Tinte Itinteang

Journal of Clinical Pathology Jan 2018, 71 (1) 88-91; DOI: 10.1136/jclinpath-2017-204815
CDK12: an emerging therapeutic target for cancer
Goldie Y L Lui, Carla Grandori, Christopher J Kemp

Journal of Clinical Pathology Nov 2018, 71 (11) 957-962; DOI: 10.1136/jclinpath-2018-205356
A multicolour flow cytometric assay for c-MYC protein in B-cell lymphoma
Khaled Alayed, Karen Schweitzer, Amad Awadallah, Shashirekha Shetty, Samir Turakhia, Howard Meyerson

Journal of Clinical Pathology Oct 2018, 71 (10) 906-915; DOI: 10.1136/jclinpath-2018-205075
Role of immunohistochemistry in the era of genetic testing in MYC-positive aggressive B-cell lymphomas: a study of 209 cases
Rishu Agarwal, Stephen Lade, Danny Liew, Toni-Maree Rogers, David Byrne, Frank Feleppa, Surender Juneja, David A Westerman

Journal of Clinical Pathology Mar 2016, 69 (3) 266-270; DOI: 10.1136/jclinpath-2015-203002

Main menu